Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05704621 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance(SOCCER-P) | recruiting | Phase 2 | 124 | Korea University Guro HospitalOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT06085404 | Patients Derived Organoids in Ovarian Cancer(PICTURE) | recruiting | N/A | 48 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER |
| 1 |
| Mar 4, 2025 |
| clinicaltrials |
| NCT06446401 | The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer(Lead4Care) | recruiting | — | 1,400 | Uppsala UniversityOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06565247 | Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation | recruiting | Phase 3 | 60 | Region VästerbottenOTHER_GOV | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06203106 | NYSCF Scientific Discovery Biobank | recruiting | — | 10,000 | New York Stem Cell Foundation Research InstituteOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT00005095 | Specimen and Data Study for Ovarian Cancer Early Detection and Prevention | recruiting | — | 6,000 | Northwestern UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06844136 | ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients(ChemoINtel) | recruiting | — | 100 | Pierian BiosciencesINDUSTRY | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06783829 | A Study of SHR-4394 Injection in Subjects With Prostate Cancer | recruiting | Phase 1 | 240 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06850545 | Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer(KuPSMALu) | recruiting | — | 150 | Kuopio University HospitalOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06845982 | Anatomopathological Evaluation of a New Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease(EFIBIA) | recruiting | N/A | 250 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06766526 | Internet-based Support for Adjustment to Prostate Cancer(ISAC) | recruiting | N/A | 180 | Linkoeping UniversityOTHER_GOV | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06841653 | A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer. | recruiting | — | 40 | Regina Elena Cancer InstituteOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05000827 | Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients(PSMA-SELECT) | recruiting | N/A | 706 | Canisius-Wilhelmina HospitalOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06169644 | The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment(PI-GTN) | recruiting | — | 20 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06818682 | Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial(RELAX) | recruiting | Phase 2 | 206 | Tata Memorial CentreOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06840418 | Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis | recruiting | N/A | 15 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06836219 | Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario(BeLIVE) | recruiting | — | 300 | Consorzio OncotechOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06242119 | Clinical Application of the J-PET Scanner Prototype(JPET2Clinic) | recruiting | — | 25 | Jagiellonian UniversityOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06082765 | Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood | recruiting | — | 10,000 | Zhongnan HospitalOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT05104515 | First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine | recruiting | Phase 1 | 36 | Oxford Vacmedix UK Ltd.INDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05829629 | Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women | recruiting | Phase 1 | 20 | BlueSky Immunotherapies GmbHINDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06820606 | Comparing Rezum and Urolift | recruiting | N/A | 120 | Chinese University of Hong KongOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06827353 | Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency(OVNI-B) | recruiting | — | 300 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05669430 | A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies | recruiting | Phase 1 / Phase 2 | 365 | GV20 TherapeuticsINDUSTRY | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06259279 | High Impact Training to Patients with Prostate Cancer and Bone Metastases(HIP) | recruiting | N/A | 102 | Copenhagen University Hospital at HerlevOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03449264 | Development of Clinical and Biological Database(BCBInstitut) | recruiting | N/A | 4,000 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT03976999 | Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers(BCBOvaire) | recruiting | N/A | 300 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04282356 | Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer(INTENS-IP) | recruiting | Phase 2 | 55 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06084195 | Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging(MR-O-MICS) | recruiting | N/A | 120 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06822582 | Pelvic Health Rehabilitation After Breast and Gynecologic Cancer(GYVE) | recruiting | N/A | 20 | Laval UniversityOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05737303 | Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer | recruiting | Phase 3 | 538 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06612047 | Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer(5TbpMRI) | recruiting | — | 150 | Anhui Provincial HospitalOTHER_GOV | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06737588 | The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer | recruiting | — | 600 | Anhui Provincial HospitalOTHER_GOV | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06783127 | Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer(COROS) | recruiting | — | 3,000 | Santa Chiara HospitalOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06819215 | Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 188 | Zhejiang Yangli Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06820333 | Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer | recruiting | — | 200 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT04057924 | Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN(SUIVICIN) | recruiting | — | 200 | University Hospital, BordeauxOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT05200260 | Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer | recruiting | Phase 2 | 220 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06123884 | BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer | recruiting | Phase 2 / Phase 3 | 526 | Bio-Thera SolutionsINDUSTRY | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06449781 | 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer(PSMA-ADJUVO) | recruiting | Phase 2 | 200 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06528184 | Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings | recruiting | N/A | 650 | National Healthcare Group PolyclinicsOTHER_GOV | 1 | Feb 10, 2025 | clinicaltrials |
| NCT04992728 | Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI | recruiting | — | 100 | University of California, San DiegoOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT05078528 | Low-cost Imaging Technology for Global Prevention of Cervical Cancer | recruiting | N/A | 1,060 | Barretos Cancer HospitalOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06028672 | Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6(TA56) | recruiting | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06785441 | Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing | recruiting | — | 180 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT06806917 | Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center | recruiting | — | 65 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT06489795 | German-funded Laparoscopic Approach to Cervical Cancer(G-LACC) | recruiting | N/A | 756 | Hannover Medical SchoolOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT06805019 | Construction of a Model for the Differential Diagnosis of SArcoma/myoma Based on the RAdiomics Features: Single-center Observational Study(SARA) | recruiting | — | 176 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT05381103 | PSMA-PET to Guide Prostatectomy | recruiting | Phase 2 / Phase 3 | 288 | Five Eleven Pharma, Inc.INDUSTRY | 1 | Jan 31, 2025 | clinicaltrials |
| NCT06468332 | Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer(PRISM-AI) | recruiting | — | 400 | Azienda Ospedaliero Universitaria Maggiore della CaritaOTHER | 1 | Jan 31, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Mar 6, 2025source: clinicaltrials